|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1001 - 0.1025|
|52 Week Range||0.0120 - 0.2700|
|Beta (5Y Monthly)||-1.24|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LAS VEGAS, NV / ACCESSWIRE / February 13, 2020 / Skinvisible, Inc. ("Skinvisible") (SKVI), is pleased to announce that it has signed a Licensing Agreement with Ovation Science Inc. for the exclusive worldwide rights to its DermSafe® hand sanitizer made with chlorhexidine gluconate. Skinvisible has signed this License Agreement with Ovation Science subject to the terms of the Agreement which includes three years of exclusivity for an on-going royalty and the option to pay a license fee after the first term. Skinvisible previously signed an exclusive licensing agreement with Ovation Science for the use of its Invisicare polymers for cannabis, hemp and hemp seed oil products.
LAS VEGAS, NV / ACCESSWIRE / October 22, 2019 / Skinvisible, Inc. ("Skinvisible") (SKVI), is pleased to announce that in conjunction with the mutual cancellation of the pending merger agreement with Quoin Pharmaceuticals, Inc. ("Quoin"), the parties have agreed to a product specific Licensing Agreement. Skinvisible has signed an Exclusive Worldwide License Agreement with Quoin.